Boston Biomedical Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2007)
Status: Acquired by Sumitomo Dainippon (2012)

Organization Overview

First Clinical Trial
2009
NCT01775423
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Boston Biomedical, Inc